Patent Assignment
Reel/Frame 070392/0541
Assignment of Assignor's Interest
Recorded: 2025-03-04
Pages: 5
Assignor
SANDOZ AG
Executed: 2015-07-13
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property
(1)
Selective Reduction of Cysteine Residues in Il-17 Antibodies
Application:
18/800,977 →
Publication:
US 2025/0034241
Related Assignments
(10)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 4, 2025
From: HEITZMANN, MARKUS
To: NOVARTIS PHARMA AG
Reel/Frame 070391/0932 →
Assignment of Assignor's Interest
Mar 4, 2025
From: WINKLER, JOHANN
To: SANDOZ GMBH
Reel/Frame 070392/0155 →
Assignment of Assignor's Interest
Mar 4, 2025
From: SANDOZ GMBH
To: SANDOZ AG
Reel/Frame 070392/0365 →
Assignment of Assignor's Interest
Mar 4, 2025
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 070392/0664 →
Assignment of Assignor's Interest
Mar 22, 2025
From: SANDOZ GMBH
To: SANDOZ AG
Reel/Frame 070594/0464 →
Assignment of Assignor's Interest
Mar 22, 2025
From: SANDOZ AG
To: NOVARTIS AG
Reel/Frame 070594/0468 →
Assignment of Assignor's Interest
Mar 22, 2025
From: HEITZMANN, MARKUS
To: NOVARTIS PHARMA AG
Reel/Frame 070594/0440 →
Assignment of Assignor's Interest
Mar 22, 2025
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 070594/0445 →
Assignment of Assignor's Interest
Mar 22, 2025
From: WINKLER, JOHANN
To: SANDOZ GMBH
Reel/Frame 070594/0459 →
Assignment of Assignor's Interest
Jun 11, 2026
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 075712/0291 →